Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERTUGLIFLOZIN PIDOLATE vs ESLICARBAZEPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERTUGLIFLOZIN PIDOLATE vs ESLICARBAZEPINE: Safety Overview

Metric ERTUGLIFLOZIN PIDOLATE ESLICARBAZEPINE
Total FAERS Reports 681 3,127
Deaths Reported 4 97
Death Rate 0.6% 3.1%
Hospitalizations 128 750
Average Patient Age 57.0 yrs 42.8 yrs
% Female Patients 56.1% 56.8%
FDA Approval Date N/A Aug 3, 2023
Manufacturer Merck Sharp & Dohme LLC Apotex Corp.
Route ORAL ORAL
Marketing Status N/A Prescription